|

R-CHOP Protocol Clinical Trials

2 actively recruiting trials

Also known as: R-CHOP regimen

Pipeline

Phase 2: 2

Top Sponsors

  • Sun Yat-sen University2

Indications

  • Cancer2
  • Diffuse Large B-cell Lymphoma(DLBCL)1
  • Diffuse Large B-Cell Lymphoma1

Other2 trials

Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial）
Phase 2
Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.